0001213900-16-014819.txt : 20160708
0001213900-16-014819.hdr.sgml : 20160708
20160707174854
ACCESSION NUMBER: 0001213900-16-014819
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160708
DATE AS OF CHANGE: 20160707
EFFECTIVENESS DATE: 20160708
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Icagen, Inc.
CENTRAL INDEX KEY: 0001518520
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 200982060
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-266588
FILM NUMBER: 161757366
BUSINESS ADDRESS:
STREET 1: 4222 EMPEROR BLVD., SUITE 350
STREET 2: RESEARCH TRIANGLE PARK
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-941-5206
MAIL ADDRESS:
STREET 1: 4222 EMPEROR BLVD., SUITE 350
STREET 2: RESEARCH TRIANGLE PARK
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: XRpro Sciences, Inc.
DATE OF NAME CHANGE: 20141204
FORMER COMPANY:
FORMER CONFORMED NAME: Caldera Pharmaceuticals Inc
DATE OF NAME CHANGE: 20110419
D
1
primary_doc.xml
X0707
D
LIVE
0001518520
Icagen, Inc.
4222 EMPEROR BLVD., SUITE 350
DURHAM
NC
NORTH CAROLINA
27703
(919) 941-5206
DELAWARE
None
XRpro Sciences, Inc.
Caldera Pharmaceuticals Inc
Corporation
true
Richard
Cunningham
4222 Emperor Blvd., Suite 350
Durham
NC
NORTH CAROLINA
27703
Executive Officer
Benjamin
Warner
4222 Emperor Blvd., Suite 350
Durham
NC
NORTH CAROLINA
27703
Director
Timothy
Tyson
4222 Emperor Blvd., Suite 350
Durham
NC
NORTH CAROLINA
27703
Director
Michael
Taglich
4222 Emperor Blvd., Suite 350
Durham
NC
NORTH CAROLINA
27703
Director
Mark
Korb
4222 Emperor Blvd., Suite 350
Durham
NC
NORTH CAROLINA
27703
Executive Officer
Vincent
Palmieri
4222 Emperor Blvd., Suite 350
Durham
NC
NORTH CAROLINA
27703
Director
Clive
Kabatznik
4222 Emperor Blvd., Suite 350
Durham
NC
NORTH CAROLINA
27703
Director
Edward
Roffman
4222 Emperor Blvd., Suite 350
Durham
NC
NORTH CAROLINA
27703
Director
Douglas
Krafte
4222 Emperor Blvd., Suite 350
Durham
NC
NORTH CAROLINA
27703
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2016-06-27
false
true
true
false
10000
Taglich Brothers, Inc.
29102
None
None
275 MADISON AVENUE
SUITE 1618
NEW YORK
NY
NEW YORK
10016
CA
CALIFORNIA
FL
FLORIDA
KS
KANSAS
MI
MICHIGAN
NY
NEW YORK
false
1145000
1145000
0
*The amount being raised was a minimum of $1,000,000
false
12
68700
true
0
true
0
true
false
Icagen, Inc.
/s/ Richard Cunningham
Richard Cunningham
Chief Executive Officer
2016-07-07